Skip To Content
Get Our Newsletter
JEWISH. INDEPENDENT. NONPROFIT.

Support the Forward

Funded by readers like you DonateSubscribe
Fast Forward

Kosher Medical Marijuana Approved In Canada, Just In Time For High Holidays

The first kosher certification for medical marijuana in Canada has been awarded to a Quebec company, the Canadian Jewish News reported Tuesday.

The Ottawa Vaad HaKashrut certification agency will place its mark on cannabis buds, powders and oils produced by the Hydropothecary Corporation of Gatineau.

The agency’s director, Rabbi Levy Teitlebaum, praised his organization’s joint effort with the medical organization.

“This is a rigorous, independent, third-party certification process that goes from A to Z,” Teitlebaum said in a statement. “Hydrothecary’s products not only qualify, but certification is gladly given because it’s important for what’s needed in this new sector.”

However, Teitelbaum was blunt when addressing the prospect of certifying recreational marijuana, which will be legal in Canada next year.

“Medical products required for health and well-being are eligible for kosher certification,” he said. “With legalization of marijuana for recreational use, however, we will have to consider the ethics of using a product simply for enjoyment.”

Contact Aiden Pink at pink@forward.com or on Twitter, @aidenpink

Engage

  • SHARE YOUR FEEDBACK

  • UPCOMING EVENT

    NY-12 Candidate Forum

    THE TEMPLE EMANU-EL STREICKER CENTER and Virtual

    Aug 10, 2022

    7 pm ET · 

    Will the last Jew left in New York’s congressional delegation be reelected? Will New York’s senior congresswoman receive another term? Or will one of the newcomers upend Manhattan politics?

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free under an Attribution-Non Commercial-No Derivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit the Foward and retain our pixel. See our full guidelines for more information.

To republish, copy the HTML, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline, images, and credit to the Foward. Have questions? Please email us at editorial@forward.com.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.